ARCHIVES

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

This article is from The Cancer Letter archive.

Vol. 18 No. 39 | October 9, 1992

Download PDF Visit The Full Archive

Related Articles

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

DCPC Board Cool Toward Moving Centers, Other Programs to New Division; Issue To NCAB May 26

May 15, 1987

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011